Picture of Telesis Bio logo

TBIO — Telesis Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Telesis Bio Inc expected to post a loss of $4.03 a share - Earnings Preview

* Telesis Bio Inc  TBIO.OQ   TBIO.O  is expected to show a
fall in
quarterly revenue when it reports  results on August 8
(estimated) for the period ending June 30 2024
    * The San Diego California-based  company is expected to
report a
24.9% decrease in revenue to $6.5 million from $8.65 million a
year ago, according to the estimate from one analyst, based on
LSEG data.
    * ​LSEG's mean analyst estimate for Telesis Bio Inc is for a
loss
of $4.03 per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​

This summary was machine generated August 7 at 02:06 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Telesis Bio

See all news